Event Listings
 
Immuno-Oncology 360° 2018, NYC

Immuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R and D, addressing aspects from all facets of IO including:
Discovery/Preclinical Science
Translational Science
Clinical Development
Business Aspects
Investor Relations
Emerging Technologies
Biomarkers / Diagnostics
Trends in the Field

Lead Advisors Dr Axel Hoos, GSK, and Dr James Gulley, NCI, developed the 4th annual IO360° program to include 45 speakers and over 30 talks. Dr Andrew Baum is the investor relations plenary keynote.

IO360° provides the most up-to-date research, data and progress to help IO stakeholders:
Be at the forefront of relevant research and developments from key leadership who are at the pulse of cancer immunotherapy
Foster collaboration amongst those working in all aspects of cancer immunotherapy together under one roof​
Receive the latest pre-clinical, translational and clinical data from academic and industry
Gain a greater understanding of what assets are available for potential combinations
Create and prioritize strategies targeted toward specific tumor types​
Hear from IO clinical trial leaders as they cover trial design, clinical operations, the latest outcomes and lessons learned
Get key investor and analyst evaluations and insights on the IO landscape, challenges and what’s next
Hear reports on industry trends from Endpoint News and BioCentury Innovations and a progress update on the Cancer Moonshot
Learn about biomarker advancements in vaccines, imaging, neoantigen approaches and more
Obtain coverage on a wide range of emerging technologies

Pharma and Biotech Special Rate:
To support IO teams in drug development, the registration fee for pharma and biotech companies includes a guest pass for a colleague from within the same company who has not yet attended IO360°. Guest pass must be claimed by Nov. 3, 2017.

Email for sponsorship and exhibitor opportunities.

URL:
Website: https://go.evvnt.com/149446-1

Prices:
Pharma and Biotech starting rate: USD 1895,
Standard Industry starting rate: USD 1895,
Academia, Non-Profit and Government starting rate: USD 947.50.

Speakers: James Gulley MD PhD, Axel Hoos MD PhD, Andrew Baum MD, Roy Baynes MD PhD, Ali Behbahani MD MBA, Jeff Bockman PhD, Bruce Booth DPhil, Lisa Butterfield PhD, Dario Campana MD PhD, John D Carroll, Jasmine Ferrer DPhil, Simone Fishburn PhD, Simeon George MD, William Grossman MD PhD, Laura Johnson PhD, Lanny Kirsch MD, Ron Korn MD PhD, Corey Langer MD FACP, Patrick Mayes PhD, Ian McCaffery PhD, Adam Millinger, Naiyer Rizvi MD, Greg Simon JD, Julius Strauss MD, Hiroomi Tada MD PhD, Jonathan Wan, Jeffrey Weber MD PhD, Cissy Young PhD MBA.

Time: 8:00 am to 5:00 pm.


Event Date: 7 February 2018 - 9 February 2018 Contact Person: IO360° Team
Venue: The Roosevelt Hotel New York, 45 East 45th Street, New York, 10017 Email:
Country: United States Tel: 646 350 2580

Registration Website: http://go.evvnt.com/149446-0

Submitted by Love Evvnt, Evvnt on Wednesday, 7 February 2018 at 8:00 AM
Category: Health Care & Medical
 
Related News

Top Shelf Quality Airbrush Tans from Gotham Glow
Sunday, 9 Dec 2018

Eczema around the Face - The best way to Get it Beneath Manage
Saturday, 8 Dec 2018

Super Nerve Power | Fibromyalgia Relief Super Nerve Power and Super Brain Power
Saturday, 8 Dec 2018

Customers Can Now Purchase Ganoderma Lucidum Spore Oil & Ganoderma Lucidum Spore Powder To Complete
Saturday, 8 Dec 2018

Systemic Lupus Erythematosus Analysis, Clinical Trials and Developments
Saturday, 8 Dec 2018

Related Events

Antibody Engineering and Therapeutics
Sunday, 9 Dec 2018

Mayo Clinic Women's Imaging Review Course
Monday, 10 Dec 2018

Antigen-Specific Immune Tolerance Europe Summit
Monday, 10 Dec 2018

International Cannabinoid Derived Pharmaceuticals Summit
Monday, 10 Dec 2018

Intensive Care Society State of the Art Conference (SOA), London 2018
Monday, 10 Dec 2018

Upcoming Events

Antibody Engineering and Therapeutics
Sunday, 9 Dec 2018

XLIVE 2018 Event Tech Conference in Las Vegas - December 9th-12th
Sunday, 9 Dec 2018

Mayo Clinic Women's Imaging Review Course
Monday, 10 Dec 2018

SPE International Heavy Oil Conference and Exhibition.
Monday, 10 Dec 2018

Intensive Care Society State of the Art Conference (SOA), London 2018
Monday, 10 Dec 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Monday, 10 December 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Latest Press Releases
  • How to find the best gasfiter in Santiago
  • Tips on how to Win Lotteries - Secrets To Picking The Winning Lottery Numbers
  • silkroad private server
  • 6 Very best Online Games It is best to Play Now
  • Draft Beer - What Variety of Bars Serve Draft Beer?

  • Latest Jobs
    Sorry, there are currently no entries posted here.